KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $3.4.

  • Idexx Laboratories' EPS (Weighted Average and Diluted) rose 2142.86% to $3.4 in Q3 2025 from the same period last year, while for Sep 2025 it was $12.61, marking a year-over-year increase of 2171.81%. This contributed to the annual value of $10.67 for FY2024, which is 601.97% up from last year.
  • Idexx Laboratories' EPS (Weighted Average and Diluted) amounted to $3.4 in Q3 2025, which was up 2142.86% from $3.63 recorded in Q2 2025.
  • Over the past 5 years, Idexx Laboratories' EPS (Weighted Average and Diluted) peaked at $3.63 during Q2 2025, and registered a low of $1.56 during Q2 2022.
  • For the 5-year period, Idexx Laboratories' EPS (Weighted Average and Diluted) averaged around $2.49, with its median value being $2.44 (2024).
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first surged by 8215.16% in 2021, then crashed by 3291.88% in 2022.
  • Idexx Laboratories' EPS (Weighted Average and Diluted) (Quarter) stood at $1.88 in 2021, then rose by 9.56% to $2.06 in 2022, then increased by 12.14% to $2.31 in 2023, then grew by 12.4% to $2.6 in 2024, then surged by 30.95% to $3.4 in 2025.
  • Its EPS (Weighted Average and Diluted) was $3.4 in Q3 2025, compared to $3.63 in Q2 2025 and $2.96 in Q1 2025.